110 patients with severe refractory epilepsy, who previously had not perceived any beneficial effects from at least three different AEDs, fulfilled the study inclusion and exclusion criteria.

This breakthrough follows GW Pharmaceuticals' $7.2 billion acquisition, highlighting the potential of cannabis-based epilepsy treatments. Argent BioPharma's CannEpil® is poised to follow a similar ...

Provide resuscitation and immediate emergency treatment for children, young people and adults who have convulsive status epilepticus (seizures lasting 5 minutes or more). If the person with convulsive ...

ganaxolone in treating refractory status epilepticus (RSE). The trial, which assessed patients whose seizures were ...